This safety report has been prepared in light of the directly erroneous conclusions of a Danish risk assessment of ashwagandha (May 2020(DTU DOCX. No. 19/1030299). The safety report clearly shows that the Danish risk assessment of ashwagandha is not applicable to KSM66. The world's most widely used and well-documented ashwagandha. For more information contact Tom Johnsson, 0705 949195, tom@medicinegarden.se
-> KSM66_studies_security March 2024_final.pdf
-> Appendix 1_SAFETY EVALUATION_ROOT PART VS. AERIAL PARTS.pdf
-> Appendix 2_Safety Opinion of Standardized Ashwagandha Root Extract.pdf
-> Appendix 3_KSM66_Studies_Safety_050324.xlsx
-> Appendix 4_Withania Safety Review AHP 2024.pdf
